| scholarly article | Q13442814 |
| P2093 | author name string | Eva van Rooij | |
| Joep E C Eding | |||
| P2860 | cites work | Cardioprotective interventions for cancer patients receiving anthracyclines | Q24245027 |
| Prevention of cardiac dysfunction during adjuvant breast cancer therapy (PRADA): a 2 × 2 factorial, randomized, placebo-controlled, double-blind clinical trial of candesartan and metoprolol | Q26768272 | ||
| Mechanisms of Anthracycline Cardiotoxicity and Strategies to Decrease Cardiac Damage | Q30439608 | ||
| MicroRNA therapeutics for cardiovascular disease: opportunities and obstacles. | Q34644199 | ||
| Mechanism of anthracycline-mediated down-regulation of GATA4 in the heart | Q34682797 | ||
| Re-patterning of skeletal muscle energy metabolism by fat storage-inducing transmembrane protein 2. | Q35604994 | ||
| Early detection of anthracycline cardiotoxicity and improvement with heart failure therapy | Q35623726 | ||
| MicroRNA-208a Silencing Attenuates Doxorubicin Induced Myocyte Apoptosis and Cardiac Dysfunction | Q35763090 | ||
| Effects of PPARα/PGC-1α on the energy metabolism remodeling and apoptosis in the doxorubicin induced mice cardiomyocytes in vitro | Q36375069 | ||
| The miRNA-212/132 family regulates both cardiac hypertrophy and cardiomyocyte autophagy. | Q36855897 | ||
| Anthracycline Chemotherapy and Cardiotoxicity. | Q37694541 | ||
| Developing microRNA therapeutics | Q37981141 | ||
| Prevalence of serum IgG and neutralizing factors against adeno-associated virus (AAV) types 1, 2, 5, 6, 8, and 9 in the healthy population: implications for gene therapy using AAV vectors | Q44258968 | ||
| Enalapril and carvedilol for preventing chemotherapy-induced left ventricular systolic dysfunction in patients with malignant hemopathies: the OVERCOME trial (preventiOn of left Ventricular dysfunction with Enalapril and caRvedilol in patients submi | Q45716509 | ||
| 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiol | Q57057529 | ||
| Non-coding RNAs: potential regulators in cardio-oncology | Q58559062 | ||
| miR-212/132 Cluster Modulation Prevents Doxorubicin-Mediated Atrophy and Cardiotoxicity | Q90348478 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | chemotherapy | Q974135 |
| drug discovery | Q1418791 | ||
| molecular medicine | Q3523816 | ||
| P304 | page(s) | 10-12 | |
| P577 | publication date | 2019-01-02 | |
| P1433 | published in | Molecular Therapy | Q15762400 |
| P1476 | title | Keeping the Heart Fitm2 during Chemotherapy | |
| P478 | volume | 27 |
Search more.